|

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

RECRUITINGSponsored by Umeå University
Actively Recruiting
SponsorUmeå University
Started2022-04-19
Est. completion2025-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05356039

Summary

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Confirmed or suspected invasive pancreatic primary tumor
* Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines

Exclusion Criteria:

* Suspected endocrine tumor
* Suspected non-pancreatic periampullary tumor
* Distant metastasis
* Age \< 18 years
* Patient unable to understand verbal or written information interfering with informed consent or treatment
* Mental or organic disorder interfering with informed consent or treatments

Conditions10

Borderline Resectable Pancreatic AdenocarcinomaCancerChemotherapy EffectLocally Advanced Pancreatic AdenocarcinomaPancreas AdenocarcinomaPancreas CancerPancreas DiseasePancreas NeoplasmQuality of LifeSurgery

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.